Search Results

Suggested Topics within your search.
Refine Results
  1. 1
    Gefitinib (Iressa®) in metastatic patients with non-small cell lung cancer: preliminary experience in a Brazilian center

    Gefitinib (Iressa®) in metastatic patients with non-small cell lung cancer: preliminary experience in a Brazilian center by Giglio, Auro del, Ito, Cristina

    Published 2004
    Get full text
    Online
    Save to List
    Saved in:
  2. 2
    EGFR, p53, IDH-1 and MDM2 immunohistochemical analysis in glioblastoma: therapeutic and prognostic correlation

    EGFR, p53, IDH-1 and MDM2 immunohistochemical analysis in glioblastoma: therapeutic and prognostic correlation by Richard Murdoch Montgomery, Luciano de Souza Queiróz, Fábio Rogério

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection

    EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection by Kyle C. Cuneo, Mukesh K. Nyati, Dipankar Ray, Theodore S. Lawrence

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions

    Molecular Targeted Therapy for Hepatocellular Carcinoma: Present Status and Future Directions by Kyung‐Ju Choi, In Hye Baik, Sang‐Kyu Ye, Yun-Han Lee

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non–Small-Cell Lung Cancer With a Detectable KRAS Mutation Whose Disease Has Progressed After Platinum-Based Chemotherapy

    Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Pati... by Jonathan W. Goldman, Peipei Shi, Martin Reck, Luis Paz‐Ares, Andrew Koustenis, Karla Hurt

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Quantitative analysis reveals how EGFR activation and downregulation are coupled in normal but not in cancer cells

    Quantitative analysis reveals how EGFR activation and downregulation are coupled in normal but not in cancer cells by Fabrizio Capuani, Alexia Conte, Elisabetta Argenzio, Luca Marchetti, Corrado Priami, Simona Polo, Pier Paolo Di Fiore, Sara Sigismund, Andrea Ciliberto

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Histologic Transformation from Adenocarcinoma to Squamous Cell Carcinoma as a Mechanism of Resistance to EGFR Inhibition

    Histologic Transformation from Adenocarcinoma to Squamous Cell Carcinoma as a Mechanism of Resistance to EGFR Inhibition by Pavel A. Levin, Melissa Mayer, Sharon Hoskin, Joseph Sailors, Dwight Oliver, David E. Gerber

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Somatic Mutation Spectrum of Non–Small-Cell Lung Cancer in African Americans: A Pooled Analysis

    Somatic Mutation Spectrum of Non–Small-Cell Lung Cancer in African Americans: A Pooled Analysis by Luiz H. Araujo, Philip E. Lammers, Velmalia Matthews-Smith, Rosana Eisenberg, Adriana González, Ann G. Schwartz, Cynthia Timmers, Konstantin Shilo, Weiqiang Zhao, Thanemozhi G. Natarajan, Jianying Zhang, Ayse Selen Yilmaz, Tom Liu, Kevin R. Coombes, David P. Carbone

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Dysregulated CRTC1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth

    Dysregulated CRTC1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth by Yoann Schumacher, Thomas Aparicio, Sarah Ourabah, Floriane Baraille, Alberto Martín, Philippe Wind, Renaud Dentin, Catherine Postic, Sandra Guilmeau

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Perspectives in the treatment of pancreatic adenocarcinoma

    Perspectives in the treatment of pancreatic adenocarcinoma by Ángel Cid-Arregui

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer

    Clinicopathologic Characteristics of the EGFR Gene Mutation in Non–small Cell Lung Cancer by Anne S. Tsao, Xi Tang, Bradley S. Sabloff, Lianchun Xiao, Hisayuki Shigematsu, Jack A. Roth, Margaret R. Spitz, Waun Ki Hong, Adi F. Gazdar, Ignacio I. Wistuba

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Nicotine Induces Inhibitor of Differentiation-1 in a Src-dependent Pathway Promoting Metastasis and Chemoresistance in Pancreatic Adenocarcinoma

    Nicotine Induces Inhibitor of Differentiation-1 in a Src-dependent Pathway Promoting Metastasis and Chemoresistance in Pancreatic Adenocarcinoma by José G. Treviño, Smitha Pillai, Sateesh Kunigal, Sandeep Singh, William J. Fulp, Barbara A. Centeno, Srikumar Chellappan

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Activation of Multiple ERBB Family Receptors Mediates Glioblastoma Cancer Stem-like Cell Resistance to EGFR-Targeted Inhibition

    Activation of Multiple ERBB Family Receptors Mediates Glioblastoma Cancer Stem-like Cell Resistance to EGFR-Targeted Inhibition by Paul A. Clark, Mari Iida, Daniel M. Treisman, Haviryaji S. G. Kalluri, Sathyapriya Ezhilan, Michael Zorniak, Deric L. Wheeler, John S. Kuo

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Identification of epidermal growth factor receptors in a hyperproducing human epidermoid carcinoma cell line.

    Identification of epidermal growth factor receptors in a hyperproducing human epidermoid carcinoma cell line. by Michael Wrann, Colin Fox

    Published 1979
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Cooperative Function of Two Separate Enhancers of the Human Epidermal Growth Factor Receptor Proto-oncogene

    Cooperative Function of Two Separate Enhancers of the Human Epidermal Growth Factor Receptor Proto-oncogene by Tomoko Maekawa, Fumio Imamoto, Glenn Merlino, Ira Pastan, Shunsuke Ishii

    Published 1989
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer

    Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer by Wei Sun, Xun Yuan, Yijun Tian, Hua Wu, Hanxiao Xu, Guoqing Hu, Kongming Wu

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib, Erlotinib, Afatinib, Dacomitinib, and Icotinib in the Treatment of Non-Small-Cell Lung Cancer: A Systematic Review

    Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib, Erlotinib, Afatinib, Dacomitinib, and Icotinib in the Treatment of Non-Small-Cell Lung Cancer: A Systematic Review by Peter Ellis, N. Coakley, Ronald Feld, S. Kuruvilla, Yee Ung

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Kinetic analysis of novel mono‐ and multivalent VHH‐fragments and their application for molecular imaging of brain tumours

    Kinetic analysis of novel mono‐ and multivalent VHH‐fragments and their application for molecular imaging of brain tumours by Umar Iqbal, Ulrike Trojahn, Homam Albaghdadi, J Zhang, Maureen D. O'Connor‐McCourt, Danica Stanimirovic, Bogusław Tomanek, Garnette R. Sutherland, Abedelnasser Abulrob

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    The intracellular tyrosine kinase domain of the epidermal growth factor receptor undergoes a conformational change upon autophosphorylation.

    The intracellular tyrosine kinase domain of the epidermal growth factor receptor undergoes a conformational change upon autophosphorylation. by Deborah L. Cadena, Chung‐leung Chan, Gordon N. Gill

    Published 1994
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells

    Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells by Sivan Bokobza, Yanyan Jiang, Anika M. Weber, Aoife Devery, Anderson J. Ryan

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: